PT Phapros, Tbk

Jakarta Stock Exchange PEHA.JK

PT Phapros, Tbk Cash and Short-Term Investments for the year ending December 31, 2023: USD 4.28 M

PT Phapros, Tbk Cash and Short-Term Investments is USD 4.28 M for the year ending December 31, 2023, a -54.72% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

PT Phapros, Tbk Cash and Short-Term Investments for the year ending December 31, 2022 was USD 9.45 M, a 43.11% change year over year.
PT Phapros, Tbk Cash and Short-Term Investments for the year ending December 31, 2021 was USD 6.60 M, a 56.74% change year over year.
PT Phapros, Tbk Cash and Short-Term Investments for the year ending December 31, 2020 was USD 4.21 M, a -49.40% change year over year.
PT Phapros, Tbk Cash and Short-Term Investments for the year ending December 31, 2019 was USD 8.33 M, a 11.09% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Jakarta Stock Exchange: PEHA.JK

PT Phapros, Tbk

CEO	Ms. Ida Rahmi Kurniasih
IPO Date	Dec. 26, 2018
Location	Indonesia
Headquarters	Rajawali Tower 17th Floor
Employees	1,384
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

PT Phapros, Tbk operates in the pharmaceutical and health care industry in Indonesia. The company operates through Over the Counter (OTC), Ethical, Generic Drugs Bearing, and Toll Manufacturing segments. It offers OTC drugs, including Antimo Anak, Livron B Plek, Noza, Hemorogard, Bioron, and others. The company also provides generic drug products for government institutions and hospitals, as well as produces drugs for other pharmaceutical industries; and offers medical devices. PT Phapros, Tbk also exports its products internationally. The company was founded in 1954 and is headquartered in Jakarta, Indonesia. PT Phapros, Tbk operates as a subsidiary of PT Kimia Farma (Persero) Tbk.

Key trends

Past 5 years